Literature DB >> 10974613

Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine.

H Weigmann1, S Härtter, M Bagli, C Hiemke.   

Abstract

Twenty male Sprague-Dawley rats received five oral doses of clomipramine 20 mg/kg at 4-h intervals. The animals were decapitated 1, 2, 3, 5 and 12 h after the last dose for determination of clomipramine and desmethylclomipramine in serum and frontal cerebral cortex. Time dependent concentrations of clomipramine and desmethylclomipramine paralleled in serum and brain. Half-lives were similar in serum and brain with 7.8 versus 6.2 h and 5.5 versus 5.0 h for clomipramine and desmethylclomipramine, respectively. Absolute concentrations, however, were markedly higher in brain than in serum - 12.5 fold for clomipramine and 7.4 fold for desmethylclomipramine. The data indicate that serum and brain concentrations of clomipramine and its demethylated metabolite are rapidly exchanged between blood and brain. Assuming that blood and brain kinetics in man and rat are comparable, it is concluded that monitoring blood concentrations of clomipramine and desmethylclomipramine is a useful way to evaluate brain concentrations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974613     DOI: 10.1016/s0924-977x(00)00098-5

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  7 in total

1.  Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters.

Authors:  Britta Haenisch; Christoph Hiemke; Heinz Bönisch
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

2.  The bio-distribution of the antidepressant clomipramine is modulated by chronic stress in mice: effects on behavior.

Authors:  Georgia Balsevich; Christian Namendorf; Tamara Gerlach; Manfred Uhr; Mathias V Schmidt
Journal:  Front Behav Neurosci       Date:  2015-01-06       Impact factor: 3.558

3.  A simple and sensitive HPLC method for analysis of imipramine in human plasma with UV detection and liquid-liquid extraction: Application in bioequivalence studies.

Authors:  Mahboubeh Rezazadeh; Jaber Emami
Journal:  Res Pharm Sci       Date:  2016 Mar-Apr

4.  Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action.

Authors:  Lewis A Quayle; Maria G Pereira; Gerjan Scheper; Tammy Wiltshire; Ria E Peake; Issam Hussain; Carol A Rea; Timothy E Bates
Journal:  Oncotarget       Date:  2017-09-13

5.  Intravenous lipid emulsion therapy for acute clomipramine intoxication in rats.

Authors:  Takumi Tsuji; Yuji Hattori; Koji Komori; Yuya Yoshida; Rie Banno; Takeyuki Kohno
Journal:  Acute Med Surg       Date:  2018-05-17

6.  Effect of Epigallocatechin-3-gallate on Stress-Induced Depression in a Mouse Model: Role of Interleukin-1β and Brain-Derived Neurotrophic Factor.

Authors:  Nabila E Abdelmeguid; Tasneem M Hammad; Ashraf M Abdel-Moneim; Sherine Abdel Salam
Journal:  Neurochem Res       Date:  2022-08-08       Impact factor: 4.414

7.  In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury-Lessons Learned.

Authors:  Anssi Lipponen; Teemu Natunen; Mika Hujo; Robert Ciszek; Elina Hämäläinen; Jussi Tohka; Mikko Hiltunen; Jussi Paananen; David Poulsen; Emilia Kansanen; Xavier Ekolle Ndode-Ekane; Anna-Liisa Levonen; Asla Pitkänen
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.